Recent Progress Toward Imaging Application of Multifunction Sonosensitizers in Sonodynamic Therapy
Chunyue Wang,Yuhang Tian,Bolin Wu,Wen Cheng
DOI: https://doi.org/10.2147/IJN.S370767
IF: 7.033
2022-08-07
International Journal of Nanomedicine
Abstract:Chunyue Wang, Yuhang Tian, Bolin Wu, Wen Cheng Department of Ultrasound, Harbin Medical University Cancer Hospital, Harbin, People's Republic of China Correspondence: Wen Cheng; Bolin Wu, Department of Ultrasound, Harbin Medical University Cancer Hospital, No. 150, Haping Road, Nangang District, Harbin, 150081, People's Republic of China, Tel +86 13313677182 ; +86 15663615088, Fax +86 451 85718392 ; +86 451 86298651, Email ; Sonodynamic therapy (SDT) is a rapidly developing non-surgical therapy that initiates sensitizers' catalytic reaction using ultrasound, showing great potential for cancer treatment due to its high safety and non-invasive nature. In addition, recent research has found that using different diagnostic and therapeutic methods in tandem can lead to better anticancer outcomes. Therefore, as essential components of SDT, sonosensitizers have been extensively explored to optimize their functions and integrate multiple medical fields. The review is based on five years of articles evaluating the combined use of SDT and imaging in treating cancer. By developing multifunctional sonosensitive particles that combine imaging and sonodynamic therapy, we have integrated diagnosis into the treatment of precision medicine applications, improving SDT cell uptake and antitumor efficacy utilizing different tumour models. This paper describes the imaging principle and the results of cellular and animal imaging of the multifunctional sonosensitizers. Efforts are made in this paper to provide data and design references for future SDT combined imaging research and clinical application development and to provide offer suggestions. Keywords: sonodynamic therapy, multifunctional sonosensitizers, imaging, ultrasound Worldwide, cancer leads the list of causes of death, and the mortality and morbidity associated with cancer are on the rise. 1 Although cancer research is expensive, cancer's variety, heterogeneity and complexity limit therapeutic choices. 2 Surgery, radiation and chemotherapy have systemic toxicity, selectivity, pharmacoresistance and possible long-term effects. Various remedies have been explored to compensate for these shortcomings. 3 SDT is a rapidly evolving, updated therapy with excellent development potential. SDT employs low-frequency ultrasound to irradiate sonosensitive substances concentrated in the treatment region to achieve the therapeutic goal of destroying aberrant cells via the toxic and physical effects. 4 Ultrasound (US) has a high tissue penetration rate and can operate on tumor cells deep into biological tissues. The therapeutic impact can be improved by using concentrated ultrasonic energy and a dynamic effect. 3 Ultrasonic waves can cause the formation of bubbles in the liquid. The bubbles then sharply shrink and break to produce mechanical damage, local high temperature and sonoluminescence, which is called inertial cavitation. 5,6 Inertial cavitation can produce reactive oxygen species (ROS) by directly decomposing the sonosensitizers or through pyrolysis with water. 7 The resulting ROS will further react with other endogenous substrates to form alkoxy and peroxyl radicals. 8 All of these adverse factors can lead to cell death, including autophagy, apoptosis, necroptosis, and pyroptosis, and limit tumor spread in sonodynamic treatment for various malignancies (Figure 1). 9–15 This method, in particular, allows for precision tumor targeting while causing minimal harm to the surrounding normal tissue. 16–19 Figure 1 Schematic illustration of the mechanism of sonodynamic therapy. The stable cavitation induced by ultrasonic irradiation promoted the sonosensitizer to enter the target area from the blood vessel, while the irradiation caused the sonosensitizers to produce ROS to kill tumour cells. On the other hand, due to the rapid advancement of diagnostic imaging technology, molecular imaging has emerged as a novel diagnostic tool with excellent resolution and sensitivity. 20 Some diagnostic imaging methods, such as photoacoustic (PA) imaging, computed tomography (CT), and magnetic resonance (MR) imaging, have high spatial resolution and penetrate deep into the tissue. 21–23 Therefore, many novel sensitizers developed by researchers combine diagnostic imaging capabilities with treatment capabilities. Nanoparticles can be treated utilizing ultrasound and may also be used to enhance the efficacy of therapy through imaging techniques to observe drug distribution, which can help calculate the best time to start treatment to develop the therapeutic effect. 24,25 As a result, the development of multifunctional drugs that combine tumour targeting, imaging, and therapeutic capabilities is critical for precision oncology. 26–28 Th -Abstract Truncated-